CRISPR Therapeutics Takeover Chatter With Vertex Puts Investor Tradeoffs In Focus

Syndax Pharmaceuticals Q4 Revenue Ramp To US$68.7 Million Tests Bullish Growth Narrative

GE HealthCare MRI And AI Deals Shape Imaging Growth Story

Trump, Israel Launch 'Massive' Attacks On Iran, Khamenei Reportedly Killed; How Will Dow Jones Futures React?

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM

How I Diagnose S&P 500 With Junk Bond Rates (DJI)